Durham, North Carolina
CNS clinical trials in Durham, NC
35 CNS studies are recruiting participants at sites in Durham as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Durham at a glance
- 35 studies are recruiting at a site in Durham.
- By phase: Phase 1/2 (4), Phase 2 (3), Phase 2/3 (1), Phase 3 (10), Phase 4 (1), No phase (9), Observational (7). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (23), university, hospital or other (11), government (1).
- By research area: Epilepsy (15), Depression (6), Parkinson's Disease (6), ADHD (3), Migraine (3), Multiple Sclerosis (2).
- Most recent update to one of these records: November 10, 2026.
Depression studies recruiting in Durham
Basic details from each study's public record (the 30 most recently updated of 35). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Families
- No phase
- Ages 12 to 100
- All sexes
- Sponsor
- Duke University
- Study site
- Duke School of Nursing
- Registry record
- NCT06627764 · updated
A New Intervention to Improve Function in Veterans With Anxiety and Depression
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- Durham VA Medical Center, Durham, NC
- Registry record
- NCT06188923 · updated
Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder
- No phase
- Ages 22 and older
- All sexes
- Sponsor
- Pulvinar Neuro, LLC
- Study site
- Qortical Clinical Partners
- Registry record
- NCT07282678 · updated
Allopregnanolone (Zuranolone) in Post-stroke Depression
- Phase 2
- Ages 21 to 65
- All sexes
- Sponsor
- Duke University
- Study site
- Duke South Neurology Clinic 1L
- Registry record
- NCT06759558 · updated
Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking
- No phase
- Ages 21 and older
- All sexes
- Sponsor
- Medical University of South Carolina
- Study site
- Duke University School of Medicine
- Registry record
- NCT07050355 · updated
Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Duke University
- Study site
- Duke University Medical Center
- Registry record
- NCT06538246 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Durham, NC on ClinicalTrials.gov.
ADHD studies recruiting in Durham
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- Duke University
- Registry record
- NCT04781140 · updated
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Observational
- Ages 0 to 20
- All sexes
- Sponsor
- Duke University
- Study site
- Duke University Health System
- Registry record
- NCT04278404 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Durham, NC on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Durham
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Duke Cancer Institute ( Site 6049)
- Registry record
- NCT06952504 · updated
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Duke University Medical Center
- Registry record
- NCT07174310 · updated
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Phase 3
- Ages 45 to 75
- All sexes
- Sponsor
- BlueRock Therapeutics
- Study site
- Duke Neurological Disorders Clinic
- Registry record
- NCT06944522 · updated
A Study of Buntanetap in Participants With PD
- Phase 2/3
- Ages 40 to 85
- All sexes
- Sponsor
- Annovis Bio Inc.
- Study site
- Duke Department of Neurosurgery
- Registry record
- NCT07284784 · updated
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Phase 2
- Ages 30 to 80
- All sexes
- Sponsor
- Appello Pharmaceuticals, Inc.
- Study site
- Duke Neurological Disorders Clinic (Site #210)
- Registry record
- NCT07432958 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Durham, NC on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Durham
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- Phase 1/2
- Ages 18 to 65
- All sexes
- Sponsor
- Tr1X, Inc.
- Study site
- Duke University
- Registry record
- NCT07477639 · updated
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- Observational
- All ages
- Female participants
- Sponsor
- Biogen
- Study site
- IQVIA US Office
- Registry record
- NCT05658497 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Durham, NC on ClinicalTrials.gov.
Epilepsy studies recruiting in Durham
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Phase 3
- Ages 4 to 55
- All sexes
- Sponsor
- SK Life Science, Inc.
- Study site
- Duke University Clinical Research at Pickett Road
- Registry record
- NCT05219617 · updated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Duke University Clinical Research
- Registry record
- NCT05667142 · updated
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Duke University Clinic
- Registry record
- NCT05716100 · updated
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
- Phase 1/2
- Ages 2 to 12
- All sexes
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Study site
- Duke University Health Systems
- Registry record
- NCT07531745 · updated
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Neurona Therapeutics
- Study site
- Duke University Hospital
- Registry record
- NCT05135091 · updated
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Phase 3
- Ages 2 and older
- All sexes
- Sponsor
- Epygenix
- Study site
- Duke University Health System
- Registry record
- NCT04462770 · updated
Diagnosing Epilepsy To EffeCT Change
- No phase
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- Duke University
- Registry record
- NCT07110337 · updated
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Encoded Therapeutics
- Study site
- Duke Children's Hospital & Health Center
- Registry record
- NCT05419492 · updated
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- Observational
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- Duke University
- Registry record
- NCT07110454 · updated
Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Duke University
- Study site
- Duke University Health System
- Registry record
- NCT06545643 · updated
Overnight TI in TLE
- No phase
- Ages 18 to 70
- All sexes
- Sponsor
- Duke University
- Study site
- Anphy Lab - Inside Hock Plaza
- Registry record
- NCT07434986 · updated
Temporal Interference Brain Stimulation for Adults With Drug-Resistant Epilepsy Undergoing Stereo-EEG Monitoring
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Duke University
- Study site
- Duke University Medical Center
- Registry record
- NCT07764718 · updated
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Phase 3
- Ages 2 to 55
- All sexes
- Sponsor
- Epygenix
- Study site
- Duke University Medical Center
- Registry record
- NCT05066217 · updated
B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Duke University
- Study site
- Duke University Medical Center
- Registry record
- NCT07271966 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Durham, NC on ClinicalTrials.gov.
Migraine studies recruiting in Durham
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Phase 3
- Ages 18 to 45
- Female participants
- Sponsor
- Pfizer
- Study site
- Carolina Women's Research and Wellness Center
- Registry record
- NCT06641466 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Durham, NC on ClinicalTrials.gov.
Ask about studies near Durham
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections